References
1. Rehfeld JF. A centenary of gastrointestinal endocrinology. Horm Metab Res 2004; 36: 735-741.
2. Zerbe CA, Washabau RJ. Gastrointestinal endocrine disease. In: Ettinger SJ, Feldman EC (eds.) Textbook of Veterinary Internal Medicine.
Philadelphia, WB Saunders, 2000; 1500-1508.3. Steiner JM, Bruyette DS. Canine insulinoma. Compend Contin Educ PractVet 1996; 18: 13-24.
4. Kraje AC. Hypoglycemia and irreversible neurologic complications in a cat with insulinoma. JAm Vet Med Assoc 2003; 223: 812-814.
5. Reimer SB, Pelosi A, Frank JD et al. Multiple endocrine neoplasia type I in a cat. J Am Vet Med Assoc 2005; 227: 101-104.
6. Hawkins KL, Summers BA, Kuhajda FP et al. Immunocytochemistry of normal pancreatic islets and spontaneous islet cell tumors in dogs. Vet Pathol 1987; 24: 170-179.
7. Fingeroth JM, Smeak DD. Intravenous methylene blue infusion for intraoperative identification of pancreatic islet-cell tumors in dogs. JAm Anim Hosp Assoc 1988; 24: 175-182.
8. Plockinger U, Rindi G, Arnold R et al. Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours - A consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS). Neuroendocrinology 2004; 80: 394-424.
9. Robben JH, Pollak YW, Kirpensteijn J et al. Comparison of ultrasonography, computed tomography, and single-photon emission computed tomography for the detection and localization of canine insulinoma. J Vet Intern Med 2005; 19: 15-22.
10. Garden OA, Reubi JC, Dykes NL et al. Somatostatin receptor imaging in vivo by planar scintigraphy facilitates the diagnosis of canine insulinomas. J Vet Intern Med 2005; 19: 168-176.
11. Vezzosi D, Bennet A, Rochaix P et al. Octreotide in insulinoma patients: efficacy on hypoglycemia, relationships with Octreoscan scintigraphy and immunostaining with anti-sst2A and anti-sst5 antibodies.
EurJ Endocrinol 2005; 152: 757-767.12. Mehlhaff CF, Peterson ME, Patnaik AK et al. Insulin-producing islet cell neoplasms: Surgical considerations and general management in 35 dogs.JAm Anim Hosp Assoc 1985; 21: 607-612.
13. Moore AS, Nelson RW, Henry CJ et al. Streptozocin for treatment of pancreatic islet cell tumors in dogs: 17 cases (1989-1999). J Am Vet Med Assoc 2002; 221: 811-818.
14. Bell R, Mooney CT, Mansfield CS et al. Treatment of insulinoma in a Springer Spaniel with streptozotocin.J Small Anim Pract 2005; 46: 247-250.
15. Meleo K. Management of insulinoma patients with refractory hypoglycemia. Probl Vet Med 1990; 2: 602-609.
16. Parker AJ, O'Brian D, Musselman EE. Diazoxide treatment of metastatic insulinoma in the dog. J Am Anim Hosp Assoc 1982; 18: 315
318.
17. Robben JH,Van den Brom WE, Mol JA et al. Effect of octreotide on plasma concentrations of glucose, insulin, glucagon, growth hormone, and cortisol in healthy dogs and dogs with insulinoma. ResVet Sci 2006; 80: 25-32.
18. Lothrop CD. Medical treatment of neuroendocrine tumors of the gastroenteropancreatic system with somatostatin. In: Kirk RW (ed.) Current Veterinary Therapy. Philadelphia, WB Saunders, 1989; 1020— 1024.
19. Caywood DD, Klausner JS, O'Leary TP et al. Pancreatic insulin-secreting neoplasms: Clinical, diagnostic, and prognostic features in 73 dogs.J Am Anim Hosp Assoc 1988; 24: 577—584.
20. Simpson KW Dykes NL. Diagnosis and treatment of gastrinoma. Seminars in Veterinary Medicine & Surgery (Small Animal) 1997; 12: 274-281.
21. Liptak JM, Hunt GB, Barrs VR et al. Gastroduodenal ulceration in cats: eight cases and a review of the literature.J Feline Med Surg 2002; 4: 27-42.
22. DiroffJS, Sanders NA, McDonough SP et al. Gastrin-secreting neoplasia in a cat. J Vet Intern Med 2006; 20: 1245-1247.
23. Pisegna JR. Zollinger-Ellison syndrome and other hypersecretory states. In: Feldman M, Friedman PA, Sleisenger MH (eds.) Gastrointestinal and liver disease.
Philadelphia, WB Saunders, 2002; 782-796.24. Patnaik AK, Lieberman PH, Erlandson RA et al. Hepatobiliary neuroendocrine carcinoma in cats: A clinicopathologic, immunohistochemical, and ultrastructural study of 17 cases. Vet Pathol 2005; 42: 331-337.
25. Lurye JC, Behrend EN. Endocrine tumors. Vet Clin North Am Small Anim Pract 2001; 31: 1083-1101.
26. Altschul M, Simpson KW, Dykes NL et al. Evaluation of somatostatin analogues for the detection and treatment of gastrinoma in a dog. J Small Anim Pract 1997; 38: 286-291.
27. Gabbert NH, Nachreiner RF, Holmes-Word P et al. Serum immunoreactive gastrin concentrations in the dog. Basal and postprandial values measured by radioimmunoassay. Am J Vet Res 1984; 45: 23512353.
28. Brooks D, Watson GL. Omeprazole in a dog with gastrinoma. J Vet Intern Med 1997; 11: 379-381.
29. Allenspach K, Arnold P, Glaus T et al. Glucagon-producing neuroendocrine tumour associated with hypoaminoacidemia and skin lesions.J SmallAnim Pract 2000; 41: 402-406.
30. Jensen AL, Norton JA. Pancreatic endocrine tumors. In: Feldman M, Friedman PA, Sleisenger MH (eds.) Gastrointestinal and liver disease. Philadelphia, WB Saunders, 2002; 988-1016.
31. Gross TL, O'Brien TD, Davies AP et al. Glucagon-producing pancreatic endocrine tumors in two dogs with superficial necrolytic dermatitis. J Am Vet Med Assoc 1990; 197: 1619-1622.
32. Torres SM, Caywood DD, O'Brien TD et al. Resolution of superficial necrolytic dermatitis following excision of a glucagon-secreting pancreatic neoplasm in a dog.J Am Anim Hosp Assoc 1997; 33: 313
319.
33. Zerbe CA, Boosinger TR, Grabau JH et al. Pancreatic polypeptide and insulin-secreting tumor in a dog with duodenal ulcers and hypertrophic gastritis.J Vet Intern Med 1989; 3: 178-182.
34. Carakostas MC, Kennedy GA, Kittelson MD et al. Malignant foregut carcinoid tumor in a domestic cat. Vet Pathol 1979; 16: 607-609.
35. Sykes GP, Cooper BJ. Canine intestinal carcinoids. Vet Pathol 1982; 19:120-131.
352